Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00706212
NCT00706212UnknownNot Applicable

A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis

Rabin Medical Center1 site in 1 country60 target enrollmentStarted: June 2008Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

PET CT is one of the imaging tools that are used for staging of urological malignancies.

C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed ~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients older then 18 years of age
  • •Full consciousness and awareness
  • •suspected to suffer from urological malignancy and a candidate for a surgical procedur

Exclusion Criteria

  • •known secondary malignancy

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

No Longer Available
Not Applicable
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyRecurrent Prostate CancerProstate Cancer
NCT02531672Memorial Sloan Kettering Cancer Center
Completed
Phase 1
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate CancerProstate Cancer
NCT00804245Wake Forest University Health Sciences18
Completed
Not Applicable
Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate CancerProstate Cancer
NCT03734757Centre Henri Becquerel20
Approved For Marketing
Not Applicable
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyCancer of the Prostate
NCT02355054Washington University School of Medicine
Completed
Phase 1
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal CancerEsophageal Cancer
NCT01051479Wake Forest University Health Sciences22
The Accuracy of CHOLINE PET CT in the... | Clinical Trial